Research Article| Volume 21, ISSUE 7, P494-500, July 2011

Download started.


Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø Study


      In this cross-sectional study we assessed the prevalence of hyperCKemia, defined as persistent CK values ⩾210 U/L in women, ⩾400 U/L in men <50 years and ⩾280 U/L in men ⩾50 years (reference values according to the Nordic Reference Interval Project).
      Blood samples were obtained from 12,828 participants in the 6th survey of The Tromsø Study. We identified 686 (5.3%) individuals with incidentally elevated CK. After a standardized control test, 169 persons (1.3%) had persistent hyperCKemia, i.e. 69.9% normalization. Use of statins or other causes of hyperCKemia were detected in 78 individuals (46.2%), giving a prevalence of “idiopathic hyperCKemia” of 0.71%. CK variation was highest in younger men and in females between 60 and 69 years. This study has identified persistent hyperCKemia in 1.3% of the normal population, and demonstrates the importance of performing controlled CK analyses, also in those with identified risk factors.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Neuromuscular Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Munsat T.L.
        • Baloh R.
        • Pearson C.M.
        • Fowler Jr., W.
        Serum enzyme alterations in neuromuscular disorders.
        JAMA. 1973; 226: 1536-1543
        • Nanji A.A.
        Serum creatine kinase isoenzymes: a review.
        Muscle Nerve. 1983; 6: 83-90
        • Hagberg M.
        • Michaelson G.
        • Ortelius A.
        Serum creatine kinase as an indicator of local muscular strain in experimental and occupational work.
        Int Arch Occup Environ Health. 1982; 50: 377-386
        • Meltzer H.Y.
        Factors affecting serum creatine phosphokinase levels in the general population: the role of race, activity and age.
        Clin Chim Acta. 1971; 33: 165-172
        • Wong E.T.
        • Cobb C.
        • Umehara M.K.
        • et al.
        Heterogeneity of serum creatine kinase activity among racial and gender groups of the population.
        Am J Clin Pathol. 1983; 79: 582-586
        • Morandi L.
        • Angelini C.
        • Prelle A.
        • et al.
        High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm.
        Neurol Sci. 2006; 27: 303-311
        • Capasso M.
        • De Angelis M.V.
        • Di Muzio A.
        • et al.
        Familial idiopathic hyper-CK-emia: an underrecognized condition.
        Muscle Nerve. 2006; 33: 760-765
        • Simmons Z.
        • Peterlin B.L.
        • Boyer P.J.
        • Towfighi J.
        Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levels.
        Muscle Nerve. 2003; 27: 242-244
        • Dabby R.
        • Sadeh M.
        • Herman O.
        • et al.
        Asymptomatic or minimally symptomatic hyperCKemia: histopathologic correlates.
        IMAJ. 2006; 8: 110-113
        • Prelle A.
        • Tancredi L.
        • Sciacco M.
        • et al.
        Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels.
        J Neurol. 2002; 249: 305-311
        • D’Adda E.
        • Sciacco M.
        • Fruguglietti M.E.
        • et al.
        Follow-up of a large population of asymptomatic/oligosymptomatic hyperckemic subjects.
        J Neurol. 2006; 253: 1399-1403
        • Reijneveld J.C.
        • Notermans N.C.
        • Linssen W.H.
        • Wokke J.H.
        Benign prognosis in idiopathic hyper-CK-emia.
        Muscle Nerve. 2000; 23: 575-579
        • Fernandez C.
        • de Paula A.M.
        • Figarella-Branger D.
        • et al.
        Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia.
        Neurology. 2006; 66: 1585-1587
        • Brewster L.M.
        • Mairuhu G.
        • Sturk A.
        • van Montfrans G.A.
        Distribution of creatine kinase in a general population: implications for statin therapy.
        Am Heart J. 2007; 154: 655-661
      1. <>.

        • Rustad P.
        • Felding P.
        • Lathi A.
        Proposal for guidelines to establish common biological reference intervals in large geographical areas for biochemical quantities measured frequently in serum and plasma.
        Clin Chem Lab Med. 2004; 42: 783-791
        • Strømme J.H.
        • Rustad P.
        • Steensland H.
        • Theodorsen L.
        • Urdal P.
        Reference intervals for eight enzymes in blood of adult females and males measured in accordance with the International Federation of Clinical Chemistry reference system at 37 degrees C: part of the Nordic Reference Interval Project.
        Scand J Clin Lab Invest. 2004; 64: 371-384
        • Black H.R.
        • Quallich H.
        • Gareleck C.B.
        Racial differences in serum creatine kinase levels.
        Am J Med. 1986; 81: 479-487
        • Nicholson G.A.
        • McLeod J.G.
        • Morgan G.
        • et al.
        Variable distributions of serum creatine kinase reference values. Relationship to exercise activity.
        J Neurol Sci. 1985; 71: 233-245
        • Brancaccio P.
        • Maffulli N.
        • Limongelli F.M.
        Creatine kinase monitoring in sport medicine.
        Br Med Bull. 2007; 81–82: 209-230
        • Serrao F.V.
        • Foerster B.
        • Spada S.
        • et al.
        Functional changes of human quadriceps muscle injury by eccentric exercise.
        Braz J Med Biol Res. 2003; 36: 781-786
        • Chan J.
        • Hui R.L.
        • Levin E.
        Differential association between statin exposure and elevated levels of creatine kinase.
        Ann Pharmacother. 2005; 39: 1611-1616
        • Hamilton-Craig I.
        Statin-associated myopathy.
        Med J Aust. 2001; 175: 486-489
        • Hippisley-Cox J.
        • Coupland C.
        Individualising the risks of statins in men and women in England and Wales: population-based cohort study.
        Heart. 2010; 96: 939-947
      2. <>.

        • Evans M.
        • Rees A.
        Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?.
        Drug Saf. 2002; 25: 649-663